FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979390930> ?p ?o ?g. }

• W2979390930 endingPage "220" @default.
• W2979390930 startingPage "215" @default.
• W2979390930 abstract "Rapid sequence induction (RSI) is recommended in patients at risk of aspiration, but induced haemodynamic adverse events, including tachycardia. In elderly patients, this trial aimed to assess the impact of the addition of remifentanil during RSI on the occurrence of: tachycardia (primary outcome), hypertension (due to intubation) nor hypotension (remifentanil).In this three-arm parallel, double blind, multicentre controlled study, elderly patients (65 to 90 years old) hospitalised in three centres and requiring RSI were randomly allocated to three groups, where anaesthesia was induced with etomidate (0.3mg/kg) followed within 15seconds by either placebo, or low (0.5μg/kg), or high (1.0μg/kg) doses of remifentanil, followed by succinylcholine 1.0mg/kg. Heart rate (HR) and mean arterial pressure (MAP) were recorded before induction and after intubation.In total, eighty patients were randomised and analysed. Baseline HR and MAP were similar between groups. For primary endpoint, the absolute change in HR between induction and intubation was greater in the control group (15 bpm; 95% CI [8-21]) than that in the remifentanil 0.5μg/kg group (4 bpm; 95% CI [-1-+8]; P=0.005) and the remifentanil 1.0μg/kg group (-3 bpm; 95% CI [-9-+3]; P<0.0001). The increase in MAP was greater in the placebo group than in both remifentanil groups (P<0.0001). Twice as many hypertension episodes were recorded in the placebo group compared to the remifentanil 0.5μg/kg and 1.0μg/kg groups (60%, 30%, and 28% patients respectively; P=0.032), but no placebo patients experienced hypotension episodes versus 11% and 24% in the remifentanil 0.5μg/kg and 1.0μg/kg groups respectively (P=0.016).Remifentanil (0.5-1.0μg/kg) prevents the occurrence of tachycardia and hypertension in elderly patients requiring RSI." @default.
• W2979390930 created "2019-10-18" @default.
• W2979390930 creator A5003671756 @default.
• W2979390930 creator A5013078395 @default.
• W2979390930 creator A5033588811 @default.
• W2979390930 creator A5034464813 @default.
• W2979390930 creator A5035958577 @default.
• W2979390930 creator A5047662523 @default.
• W2979390930 creator A5049906055 @default.
• W2979390930 creator A5081310173 @default.
• W2979390930 date "2020-04-01" @default.
• W2979390930 modified "2023-09-26" @default.
• W2979390930 title "Efficacy and safety of remifentanil in a rapid sequence induction in elderly patients: A three-arm parallel, double blind, randomised controlled trial" @default.
• W2979390930 cites W1588294016 @default.
• W2979390930 cites W1986897777 @default.
• W2979390930 cites W1994593568 @default.
• W2979390930 cites W2004982947 @default.
• W2979390930 cites W2016909580 @default.
• W2979390930 cites W2022697972 @default.
• W2979390930 cites W2024687868 @default.
• W2979390930 cites W2064605769 @default.
• W2979390930 cites W2065666965 @default.
• W2979390930 cites W2079609696 @default.
• W2979390930 cites W2099916354 @default.
• W2979390930 cites W2104383969 @default.
• W2979390930 cites W2108003556 @default.
• W2979390930 cites W2112141608 @default.
• W2979390930 cites W2130384178 @default.
• W2979390930 cites W2137336105 @default.
• W2979390930 cites W2159813665 @default.
• W2979390930 cites W2167600089 @default.
• W2979390930 cites W2286415593 @default.
• W2979390930 cites W2770889812 @default.
• W2979390930 cites W4249675121 @default.
• W2979390930 doi "https://doi.org/10.1016/j.accpm.2019.09.010" @default.
• W2979390930 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31614244" @default.
• W2979390930 hasPublicationYear "2020" @default.
• W2979390930 type Work @default.
• W2979390930 sameAs 2979390930 @default.
• W2979390930 citedByCount "6" @default.
• W2979390930 countsByYear W29793909302020 @default.
• W2979390930 countsByYear W29793909302021 @default.
• W2979390930 countsByYear W29793909302022 @default.
• W2979390930 countsByYear W29793909302023 @default.
• W2979390930 crossrefType "journal-article" @default.
• W2979390930 hasAuthorship W2979390930A5003671756 @default.
• W2979390930 hasAuthorship W2979390930A5013078395 @default.
• W2979390930 hasAuthorship W2979390930A5033588811 @default.
• W2979390930 hasAuthorship W2979390930A5034464813 @default.
• W2979390930 hasAuthorship W2979390930A5035958577 @default.
• W2979390930 hasAuthorship W2979390930A5047662523 @default.
• W2979390930 hasAuthorship W2979390930A5049906055 @default.
• W2979390930 hasAuthorship W2979390930A5081310173 @default.
• W2979390930 hasBestOaLocation W29793909301 @default.
• W2979390930 hasConcept C126322002 @default.
• W2979390930 hasConcept C141071460 @default.
• W2979390930 hasConcept C142724271 @default.
• W2979390930 hasConcept C168563851 @default.
• W2979390930 hasConcept C178853913 @default.
• W2979390930 hasConcept C197934379 @default.
• W2979390930 hasConcept C203092338 @default.
• W2979390930 hasConcept C204787440 @default.
• W2979390930 hasConcept C27081682 @default.
• W2979390930 hasConcept C2776277131 @default.
• W2979390930 hasConcept C2776452961 @default.
• W2979390930 hasConcept C2777953023 @default.
• W2979390930 hasConcept C2778716859 @default.
• W2979390930 hasConcept C2778891214 @default.
• W2979390930 hasConcept C2780283014 @default.
• W2979390930 hasConcept C42219234 @default.
• W2979390930 hasConcept C71924100 @default.
• W2979390930 hasConcept C84393581 @default.
• W2979390930 hasConceptScore W2979390930C126322002 @default.
• W2979390930 hasConceptScore W2979390930C141071460 @default.
• W2979390930 hasConceptScore W2979390930C142724271 @default.
• W2979390930 hasConceptScore W2979390930C168563851 @default.
• W2979390930 hasConceptScore W2979390930C178853913 @default.
• W2979390930 hasConceptScore W2979390930C197934379 @default.
• W2979390930 hasConceptScore W2979390930C203092338 @default.
• W2979390930 hasConceptScore W2979390930C204787440 @default.
• W2979390930 hasConceptScore W2979390930C27081682 @default.
• W2979390930 hasConceptScore W2979390930C2776277131 @default.
• W2979390930 hasConceptScore W2979390930C2776452961 @default.
• W2979390930 hasConceptScore W2979390930C2777953023 @default.
• W2979390930 hasConceptScore W2979390930C2778716859 @default.
• W2979390930 hasConceptScore W2979390930C2778891214 @default.
• W2979390930 hasConceptScore W2979390930C2780283014 @default.
• W2979390930 hasConceptScore W2979390930C42219234 @default.
• W2979390930 hasConceptScore W2979390930C71924100 @default.
• W2979390930 hasConceptScore W2979390930C84393581 @default.
• W2979390930 hasIssue "2" @default.
• W2979390930 hasLocation W29793909301 @default.
• W2979390930 hasLocation W29793909302 @default.
• W2979390930 hasLocation W29793909303 @default.
• W2979390930 hasLocation W29793909304 @default.
• W2979390930 hasOpenAccess W2979390930 @default.
• W2979390930 hasPrimaryLocation W29793909301 @default.
• W2979390930 hasRelatedWork W1980410714 @default.

• next